OmniAb, Inc.
NASDAQ: OABIW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Matthew W. Foehr
- Employees
- 114
- Headquarters
- EmeryVille, United States
- IPO year
- 2021
- Market cap
- $303.1M
- Website
- https://www.omniab.com
Loading OABIW…
Loading profile data…Frequently asked questions about OABIW
What does OmniAb, Inc. (OABIW) do?
OmniAb, Inc., established in 2012 and headquartered in Emeryville, California, operates as a biotechnology firm focused on pioneering technologies for the discovery of therapeutic antibodies within the United States. The company's flagship offering is its OmniAb platform, which provides industry collaborators with access to a broad spectrum of a...
Where does OABIW trade?
OmniAb, Inc. (OABIW) trades on the NASDAQ Capital Market.
What sector is OABIW in?
OmniAb, Inc. (OABIW) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of OmniAb, Inc.?
Matthew W. Foehr is the chief executive officer of OmniAb, Inc. (OABIW).
Where is OmniAb, Inc. headquartered?
OmniAb, Inc. is headquartered in United States.
Does OABIW pay a dividend?
OmniAb, Inc. (OABIW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OABIW go public?
OmniAb, Inc. (OABIW) completed its initial public offering in 2021.